| Literature DB >> 29439566 |
Nidhi Kakkar1, Jessica G Perez2, Wenshe R Liu3, Michael C Jewett2, Wilfred A van der Donk1.
Abstract
Lantibiotics are ribosomally synthesized and post-translationally modified peptide natural products that contain thioether cross-links formed by lanthionine and methyllanthionine residues. They exert potent antimicrobial activity against Gram-positive bacteria. We herein report production of analogues of two lantibiotics, lacticin 481 and nisin, that contain nonproteinogenic amino acids using two different strategies involving amber stop codon suppression technology. These methods complement recent alternative approaches to incorporate nonproteinogenic amino acids into lantibiotics.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29439566 PMCID: PMC5910287 DOI: 10.1021/acschembio.7b01024
Source DB: PubMed Journal: ACS Chem Biol ISSN: 1554-8929 Impact factor: 5.100